PolyU showcased its impactful innovations in biotechnology and life sciences at the prestigious BIO International Convention (BIO 2024) in San Diego, USA. As the sole university representing Hong Kong, PolyU aimed to connect with global industry leaders and explore collaboration opportunities to elevate the international recognition of its research accomplishments.

The annual BIO International Convention is the largest and most comprehensive biotechnology event, attracting over 19,500 attendees from 70 countries this year. PolyU's booth at the convention highlighted a range of projects, including a fungus and plant-based supplement for obesity and prediabetes, a lightweight ankle exoskeleton for stroke rehabilitation, a portable nucleic acid testing system, Chinese herb-derived dimers for osteochondral repair, and eco-friendly antimicrobial materials.

In addition to showcasing the research projects, Ynno Med Limited, a PolyU-nurtured startup, also participated in the Hong Kong Pavilion as one of the companies from the HKSTP delegation. 
 

Dr Ma Cong (right) hopes novel antibiotics can address the mounting threat of AMR worldwide.

Ynno Med, co-founded by Dr Ma Cong, Associate Professor of the Department of Applied Biology and Chemical Technology, is at the forefront of developing groundbreaking antimicrobial resistance (AMR) medicines. Ynno Med's innovative AI-assisted platform enables the discovery of novel targets for antimicrobials while suppressing resistance generation at a lower cost. Promising preliminary results from preclinical studies have allowed Ynno Med to progress its drug candidate to clinical trials. The company has also formed a strategic partnership with Shanghai Pharmaceuticals Holding to expedite the approval process in the Mainland.

PolyU's presence at BIO 2024 highlights the University's dedication to advancing biotechnology and life sciences through cutting-edge research and innovation.